IBL is dedicated to the systematic study and application of knowledge and understanding to determine the means by which a recognized and specific need may be met. Our end result is the development toward the production of useful materials, devices, and systems or methods, including design, development, and improvement of prototypes and new processes to meet these specific requirements in enhancing better life expectancy.

IBL intends to take R&D to another dynamic level in Africa and be a pioneer in championing methods and researches in the biotechnology industry.

In furtherance of its research and development’s programme, IBL plans to set up a world class clinical trial facility in Keffi, Nasarawa state.

Clinical trials are forms of investigation conducted in human subjects intended to discover or verify the safety and/or efficacy of an investigational product(s), before it is licensed for general use by the public. It is a critical step in the development process of any new drug, vaccine or treatment.